Loading...
Market
What will be the revenue generated by the new Alzheimer's blood test in its first year of market availability by August 5, 2025?
2
Resolution / Starting Odds
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $200 million • 25%
More than $200 million • 25%
Financial reports from ADmit Therapeutics and market analysis reports
Story
New Blood Test for Early Detection of Alzheimer’s Shows High Diagnostic Accuracy, Aiding Clinical Trials
Aug 5, 2024, 01:02 PM
Researchers have developed a new blood test to detect Alzheimer’s disease, which can diagnose the disease even at the early stage of mild cognitive impairment. This advancement is expected to improve the path to better diagnosis and faster access to clinical trials and early treatment for Alzheimer’s disease. A study published in the JAMA Network during the AAIC24 conference found that the blood test had high diagnostic accuracy for identifying Alzheimer’s among adults with cognitive symptoms. The test, developed by Marta Barrachina, PhD, and her team at @ADmitTherapeut1, could make clinical trials more efficient and effective, generating hope for early detection and timely access to new treatments.
View original story
Similar markets
PrecivityAD2™ dominates (>50%) • 25%
Sunbird Bio dominates (>50%) • 25%
Both share equally (~50% each) • 25%
Other diagnostic tests dominate • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
Below $100 million • 25%
$100 million - $200 million • 25%
$200 million - $300 million • 25%
Above $300 million • 25%
Yes • 50%
No • 50%
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $150 million • 25%
More than $150 million • 25%
Pfizer • 25%
Roche • 25%
Eli Lilly • 25%
Other • 25%
Less than 20% • 25%
20%-40% • 25%
40%-60% • 25%
More than 60% • 25%
Widely adopted (>75% of clinics) • 25%
Moderately adopted (50-75% of clinics) • 25%
Sparsely adopted (25-50% of clinics) • 25%
Rarely adopted (<25% of clinics) • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
More than $1.5 billion • 25%
Below $2.4 billion • 25%
$2.4 billion to $2.5 billion • 25%
$2.5 billion to $2.6 billion • 25%
Above $2.6 billion • 25%
Above $100 million • 25%
Between $50 million and $100 million • 25%
Between $10 million and $50 million • 25%
Below $10 million • 25%
Less than $100M • 25%
$100M - $500M • 25%
$500M - $1B • 25%
More than $1B • 25%